Tuesday, 17 September - Friday, 20 September 2019
Abstract Submission is now open and available via the MyEASD platform. If you are a member of EASD or you have already an account for the EASD Virtual Meeting or Annual Meeting registration, you can use the login details from your existing account (email address and password) to login to MyEASD and access the Abstract Submission System for the 55th EASD Annual Meeting. All other users / abstract submitters will need to create a MyEASD account to have access. The submission deadline is 1 April 2019.
Communications must be delivered in English. There is no simultaneous translation.
It is not permitted to take photographs and/or film during any of the sessions.
Receipt of Abstract
Abstracts can only be submitted online and MUST be submitted BEFORE 1 APRIL 2019 23:59 hrs CEST. THIS DEADLINE WILL BE STRICTLY ENFORCED, as will be the regulations given below. The EASD office will notify the presenting (= first named) author when the abstracts with the status "complete" are forwarded for anonymous review.
Submission of Abstracts
The following is a brief overview of the abstract submission process. Please read carefully the DETAILED ABSTRACT SUBMISSION GUIDELINES before you begin the abstract submission process.
It is not permitted to submit work that has been published and/or is likely to be published before the EASD Abstract submission deadline (1 April 2019, 23:59 hrs. CEST). The Programme Committee has the right to remove an abstract if this contains data that has already been published. However, EASD accepts the submission of abstracts that have been presented in recent months at local or national diabetes meetings (e.g. ADA, DDG). An author submitting or presenting work that has been published in a journal before the EASD Abstract submission deadline (1 April 2019, 23:59hrs CEST) will be banned from presenting data at the EASD Meetings for three years.
Abstracts submitted on Human Studies:
The box must be marked stating that the study has been reviewed by the Local Ethics Committee and that it has therefore been performed in accordance with the ethical standards laid down in the Helsinki Declaration (see World Medical Association: www.wma.net).
Abstracts submitted on Animal Studies:
The box must be marked stating that the study has been carried out along the “Principles of laboratory animal care” (NIH Publication no. 85-23, revised 1985) and according to the national law, if applicable.
Selection of abstracts for the Scientific Programme is made anonymously. THE ABSTRACT MUST BE SUBMITTED as follows:
Each author can be listed ONLY ONCE as the PRESENTING author (presenting author is always the first named author in the author block) on ONE (1) abstract. Each additional abstract will be removed from the system and will not be forwarded to the Review Committee. Additional abstracts will not be reviewed. Presenting authors may be co-authors of other abstracts. It is mandatory that the presenting author of any abstract accepted for presentation attends the 55th EASD Annual Meeting 2019 to present his / her paper. Failure to do so, without prior or adequate explanation sent to the EASD Office by e-mail, may result in the author or the institution being banned from presenting abstracts for the next three years.
Abstracts are welcome from non-members of EASD. Please refer to the Registration section of this General Information, regarding the date by which authors must become members of EASD in order to qualify for preferential registration fees. These regulations will be strictly enforced.
The abstract must be submitted in English. New authors should create an account using a login name and a password. With this information they can revise the submission as often as required, make changes, additions, amendments, change/add/delete authors, copy special characters easily into the text, re-write the abstract or copy and paste the text in the corresponding boxes. All this is possible until the Abstract Submission Deadline: 1 April 2019 23:59 hrs CEST. After this date the submission site will be closed. IMPORTANT!: Always double check that the “complete” status of your submitted abstract has NOT been affected after having edited it.
CHANGES TO THE CONTENT AND/OR THE AUTHOR BLOCK OF THE SUBMITTED ABSTRACT WILL NOT BE ACCEPTED after the submission deadline.
Your abstract submission must adhere the following structure:
In case of questions, or if you have not received a reply by 15 April 2019, please call: +49-211-75 84 69 0 or contact email@example.com.
One keyword from the list below must be selected for the submission:
GROUP 1: Genetics/Epigenetics/Epidemiology
02 Genetics of type 1 diabetes
03 Genetics of type 2 diabetes
04 Monogenic forms of diabetes
05 Environmental factors (viruses, nutrients, toxins)
06 Diabetes epigenetics
07 Prediction and prevention of type 1 diabetes
08 Prediction of type 2 diabetes
09 Prevention of type 2 diabetes
10 Risk of diabetes in immigrant populations
GROUP 2: Islets/Transplantation/Immunology of type 1 diabetes
11 Developmental biology of the pancreas
12 Stem cells and beta cell generation
13 Transcriptional regulation and protein synthesis in the pancreas
14 Insulin secretion in vitro and exocytosis
15 Beta cell signal transduction
16 Beta cell damage, degeneration and apoptosis
17 Experimental immunology and animal models of type 1 diabetes
18 Clinical immunology
19 Inflammatory mediators in the pathogenesis of type 1 diabetes
20 Pancreas and islet transplantation
GROUP 3: Pathophysiology/Metabolism I
21 Insulin action
22 Insulin sensitivity and resistance
23 Insulin secretion in vivo
24 Gastro-entero pancreatic factors
25 Other hormones
26 Glucose transport
27 Carbohydrate metabolism
28 Protein metabolism
29 Exercise physiology
GROUP 4: Pathophysiology/Metabolism II
30 Inflammation in type 2 diabetes
31 Animal models of type 2 diabetes
32 Lipid metabolism
33 Adipose tissue biology and adipocytokines
34 Inflammation in obesity
35 Animal models of obesity
36 Weight regulation and obesity
37 Brain metabolism
38 Ageing and diabetes: molecular aspects
GROUP 5: Clinical Science and Care I
39 Nutrition and diet
40 Oral therapies: secretagogues
41 Oral therapies: metformin, sensitizers and other non-secretagogues
42 SGLT inhibitors
43 Incretin based therapies
44 Novel agents
GROUP 6: Clinical Science and Care II
45 Insulin therapy
48 Health care delivery
50 Psychological aspects
51 Socio-economic aspects
52 Digital diabetes health
GROUP 7: Complications I
54 Neuropathy: somatic
55 Neuropathy: autonomic, incl. erectile dysfunction
56 Diabetic foot and skin disorders
GROUP 8: Complications II/Comorbidities
60 Cardiac complications
61 Macrovascular disease
62 Pathogenic mechanisms / complications
63 Dyslipidaemia, lipoproteins
65 Animal models of complications
66 Other complications
67 Diabetes in childhood
69 Cognitive dysfunction and Alzheimer Disease
70 Non-alcoholic fatty liver disease (NAFLD)
71 Ageing and diabetes: clinical aspects
Preference for oral or poster presentation is not possible. The Programme Committee allocates the accepted abstracts to either an oral or a poster session. The Programme Committee Members will meet end of May 2019 and have the absolute right to accept or reject abstracts. Their decision is final. Only accepted abstracts will be published in the Abstract Volume. The Programme Committee’s decision will be communicated via email in the first week of June 2019 ONLY to the presenting (= first named) author’s contact e-mail entered in the online abstract submission tool.
Poster presentations rank equally with oral presentations at EASD Meetings. Posters must be on display throughout the whole duration of the Meeting and should be already mounted in the morning of the first day and removed at the end of the EASD Meeting. The Posters must be accessible for study at any time during the hours of the Annual Meeting.
All posters are presented at special, formal Poster Discussion Sessions which will be held from Tuesday to Thursday from 12:00 - 14:15. These sessions offer an excellent opportunity for direct scientific exchange. During the Poster Presentation Sessions, the presenting author must be present or make arrangements for somebody with knowledge of the displayed work to be present at the poster. An average of 3 - 5 minutes will allow for each author to present his/her poster, followed by open discussion of 3 - 5 minutes (depending on the number of abstracts in the poster session). Participants can collect a headset on a first come first served basis to follow the presentations within the corresponding sessions. Reprints of the poster (e.g. sheets of DIN A4 format) should be made available (no booklets). Detailed instructions will be sent to the presenting author on notification of acceptance (ONLY to the presenting (= first named) author’s contact e-mail entered in the online abstract submission tool) online abstract submission tool).
Third-party Poster Tours / Sessions are STRICTLY FORBIDDEN.
In addition to the printed poster presentation, EASD will also make posters available via its Virtual Meeting. For the EASD Virtual Meeting you can also record an e-poster video presentation (onsite and by appointment only) or an audio commentary to accompany your poster presentation.
PowerPoint presentation will be available for Oral Presentations. Instructions on presentation will be sent to the presenting authors on notification of acceptance (ONLY to the presenting (= first named) author’s contact e-mail entered in the online abstract submission tool). Only single projection is provided.
Oral Presentations during the EASD Annual Meeting will also be made available as webcasts via the EASD Virtual Meeting.
Registration will open in February 2019.
Fira de Barcelona
Av. Joan Carles I, 64
Advisory - Unofficial Hotel Booking and Registration Agencies
Please be aware that there are unofficial agencies that offer housing and registration for the 55th EASD Annual Meeting that are not linked to EASD.
Please use only the official registration system and the official hotel booking agency from the EASD website or established, reputable third party websites or agencies.
EASD cannot be held responsible for any losses incurred as a result of bookings made through unofficial websites. Should you be contacted by, or find such an operation online, we kindly ask you to inform us as soon as possible.
A limited number of Travel Grants will be available to presenting authors of accepted abstracts. Applications may be made by any paid-up member of EASD not yet holding a title or academic degree (students) or from scientists conducting research after completion of the doctoral studies (postdocs/fellows).
The deadline for Travel Grant Applications is Monday, 1 July 2019, 23:59 (CET).
Application for Travel Grants
Please download and complete the Application Form. Please submit the application by email including the supporting documents:
Only applications that fulfil all the above requirements will be considered for a 2019 Travel Grant. Please send your application form and the supporting documents to: firstname.lastname@example.org.
Monday, 16 September 2019
Wednesday, 18 September 2019
Thursday, 19 September 2019